Polymyositis-dermatomyositis-associated interstitial lung disease

被引:385
作者
Douglas, WW
Tazelaar, HD
Hartman, TE
Hartman, RP
Decker, PA
Schroeder, DR
Ryu, JH
机构
[1] Mayo Clin & Mayo Fdn, Div Pulm & Crit Care Med, Rochester, MN 55905 USA
[2] Mayo Clin & Mayo Fdn, Div Anat Pathol, Rochester, MN 55905 USA
[3] Mayo Clin & Mayo Fdn, Dept Diagnost Radiol, Rochester, MN 55905 USA
[4] Mayo Clin & Mayo Fdn, Biostat Sect, Rochester, MN 55905 USA
关键词
polymyositis-dermatomyositis; interstitial lung disease; survival; azathioprine; prednisone;
D O I
10.1164/ajrccm.164.7.2103110
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
We report findings in 70 patients with both diffuse interstitial lung disease and either polymyositis (PM) or dermatomyositis (DM). Initial presentations were most commonly either musculoskeletal (arthralgias, myalgias, and weakness) or pulmonary (cough, dyspnea, and fever) symptoms alone; in only 15 patients (21.4%) did both occur simultaneously. Pulmonary disease usually took the form of acute to subacute antibiotic-resistant community-acquired pneumonia. Chest radiographs and computed tomography most commonly demonstrated bilateral irregular linear opacities involving the lung bases; occasionally consolidation was present. Jo-1 antibody was present in 19 (38%) of 50 patients tested. Synchronous associated malignancy was present in 4 of 70 patients (5.7%). Surgical lung biopsies disclosed nonspecific interstitial pneumonia (NSIP) in 18 of 22 patients (81.8%), organizing diffuse alveolar damage (DAD) in 2, bronchiolitis obliterans organizing pneumonia (BOOP) in 1, and usual interstitial pneumonia (UIP) in 1. Treatment usually included prednisone in 40-60 mg/d dosages for initial control, followed by lower dose prednisone plus an immunosuppressive agent such as azathioprine or methotrexate for disease suppression. Survival was significantly better than that observed for historical control subjects with idiopathic UIP, and was more consistent with survival previously reported in idiopathic NSIP. There was no difference in survival between Jo-1 positive and Jo-1 negative groups.
引用
收藏
页码:1182 / 1185
页数:4
相关论文
共 25 条
[1]   Interstitial lung disease in association with polymyositis-dermatomyositis: Long-term follow-up CT evaluation in seven patients [J].
Akira, M ;
Hara, H ;
Sakatani, M .
RADIOLOGY, 1999, 210 (02) :333-338
[2]  
[Anonymous], 2000, AM J RESP CRIT CARE, V161, P646, DOI DOI 10.1164/AJRCCM.161.2.ATS3-00
[3]   Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis [J].
Bjoraker, JA ;
Ryu, JH ;
Edwin, MK ;
Myers, JL ;
Tazelaar, HD ;
Schroeder, DR ;
Offord, KP .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1998, 157 (01) :199-203
[4]   POLYMYOSITIS AND DERMATOMYOSITIS .2. [J].
BOHAN, A ;
PETER, JB .
NEW ENGLAND JOURNAL OF MEDICINE, 1975, 292 (08) :403-407
[5]   POLYMYOSITIS AND DERMATOMYOSITIS .1. [J].
BOHAN, A ;
PETER, JB .
NEW ENGLAND JOURNAL OF MEDICINE, 1975, 292 (07) :344-347
[6]   PREDNISONE AND AZATHIOPRINE FOR POLYMYOSITIS - LONG-TERM FOLLOW-UP [J].
BUNCH, TW .
ARTHRITIS AND RHEUMATISM, 1981, 24 (01) :45-48
[7]   AZATHIOPRINE WITH PREDNISONE FOR POLYMYOSITIS - CONTROLLED, CLINICAL-TRIAL [J].
BUNCH, TW ;
WORTHINGTON, JW ;
COMBS, JJ ;
ILSTRUP, DM ;
ENGEL, AG .
ANNALS OF INTERNAL MEDICINE, 1980, 92 (03) :365-369
[8]   A histologic pattern of nonspecific interstitial pneumonia is associated with a better prognosis than usual interstitial pneumonia in patients with cryptogenic fibrosing alveolitis [J].
Daniil, ZD ;
Gilchrist, FC ;
Nicholson, AG ;
Hansell, DM ;
Harris, J ;
Colby, TV ;
du Bois, RM .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 160 (03) :899-905
[9]   PULMONARY-DISEASE IN POLYMYOSITIS DERMATOMYOSITIS [J].
DICKEY, BF ;
MYERS, AR .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 1984, 14 (01) :60-76
[10]   Idiopathic pulmonary fibrosis - Impact of oxygen and colchicine, prednisone, or no therapy on survival [J].
Douglas, WW ;
Ryu, JH ;
Schroeder, DR .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2000, 161 (04) :1172-1178